Assessment of Patient's Satisfaction Regarding the Handiness of Two Hyaluronic Acid Eye Drops Vials

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Assess the patient feeling about the handiness of two different vials used to deliver both, unpreserved hyaluronic eye drops.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Comparison of Two Types of Artificial Tears

NCT05356728

Dry Eye Disease

UNKNOWN NA

Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye Syndrome

NCT01864330

Dry Eye Syndrome

COMPLETED PHASE4

Efficacy and Safety of Different Hyaluronic Acid Tear Substitutes Formulations in Evaporative Dry Eye

NCT06517667

Dry Eye

COMPLETED PHASE2/PHASE3

Evaluation of Dry Eye Disease's Signs in Patients Who Were Administered Intravitreal Anti-VEGF Injections

NCT06317922

Dry Eye Syndromes

RECRUITING NA

Anti-inflammatory Effects and Clinical Efficacy of Topical Thealoz Total Eye Drops in Patients With Chronic Dry Eye Disease

NCT07007702

Dry Eye Disease (DED)

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Assess the Patient Feeling About the Handiness of Two Different Vials Used to Deliver Both, Unpreserved Hyaluronic Eye Drops

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HYABAK®

Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)

Group Type EXPERIMENTAL

HYABAK®

Intervention Type DEVICE

Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)

HYLO-COMOD®:

Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)

Group Type ACTIVE_COMPARATOR

HYLO-COMOD®

Intervention Type DEVICE

Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

HYABAK®

Hyaluronic Acid eye drops CE marked, packaged in multidose ABAK® container (preservative free)

Intervention Type DEVICE

HYLO-COMOD®

Hyaluronic Acid eye drops CE marked, packaged in multidose COMOD® container (preservative free)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Man or woman aged 18 and older
* Patient with dry eye for at least 3 months
* Having given his written informed consent

Exclusion Criteria

* Intolerance to studied products
* Patient's inability to understand the study procedures and give informed consent.
* Patient unwilling to follow the study procedures and visits defined by the protocol.
* Pregnant or lactating women.
* Patient under guardian ship

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No